The National Institute for Health and Clinical Excellence (NICE) has opened a consultation on a new medical technology device to promote wound healing. The medical technology guidance draft was produced by the Medical Technologies Advisory Committee (MTAC), part of the Medical Technologies Evaluation Programme at NICE.
The MIST Therapy system claims to promote wound healing in chronic and acute wounds by delivering low-energy, lowintensity ultrasound to the base of the wound through a continuous saltwater mist. The mist acts as a channel for transmitting ultrasonic energy to the base of the wound, which aims to reduce the amount of bacteria in the wound and stimulate tissue regeneration. The treatment lasts around five minutes and is carried out three times a week, at the same time that wound dressings are changed. The Committee’s view is that the device shows promise, and its use is supported by expert opinion. However, there is not yet enough evidence of sufficient quality to enable the Committee to make a positive recommendation on its use.
